MA26416A1 - Perles pharmaceutiques a liberation controlee contenant du furosemide et une composition realisee avec les dites perles. - Google Patents

Perles pharmaceutiques a liberation controlee contenant du furosemide et une composition realisee avec les dites perles.

Info

Publication number
MA26416A1
MA26416A1 MA24443A MA24443A MA26416A1 MA 26416 A1 MA26416 A1 MA 26416A1 MA 24443 A MA24443 A MA 24443A MA 24443 A MA24443 A MA 24443A MA 26416 A1 MA26416 A1 MA 26416A1
Authority
MA
Morocco
Prior art keywords
pearls
controlled release
release pharmaceutical
composition made
containing furosemide
Prior art date
Application number
MA24443A
Other languages
English (en)
Inventor
Hans Arwidsson
Maria Eriksson
Lars Stubberud
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of MA26416A1 publication Critical patent/MA26416A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA24443A 1996-01-05 1996-12-26 Perles pharmaceutiques a liberation controlee contenant du furosemide et une composition realisee avec les dites perles. MA26416A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9600046A SE9600046D0 (sv) 1996-01-05 1996-01-05 New pharmaceutical formulation

Publications (1)

Publication Number Publication Date
MA26416A1 true MA26416A1 (fr) 2004-12-20

Family

ID=20400947

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24443A MA26416A1 (fr) 1996-01-05 1996-12-26 Perles pharmaceutiques a liberation controlee contenant du furosemide et une composition realisee avec les dites perles.

Country Status (7)

Country Link
AU (1) AU1323897A (fr)
HR (1) HRP970004A2 (fr)
MA (1) MA26416A1 (fr)
SE (1) SE9600046D0 (fr)
TN (1) TNSN97001A1 (fr)
WO (1) WO1997025028A1 (fr)
ZA (1) ZA9610888B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01004381A (es) 1998-11-02 2005-09-08 Elan Corp Plc Composicion de multiparticulado de liberacion modificada.
FR2796840B1 (fr) 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
KR100889069B1 (ko) 1999-10-29 2009-03-17 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
AU2738302A (en) 2000-10-30 2002-05-15 Euro Celtique Sa Controlled release hydrocodone formulations
US20030091633A1 (en) * 2001-11-15 2003-05-15 John Kelly Methods and compositions for use of (S)-bisoprolol
IL160095A0 (en) * 2004-01-28 2004-06-20 Yissum Res Dev Co Formulations for poorly soluble drugs
DK1669074T3 (da) * 2004-12-01 2010-09-27 Par Pharmaceuticals Inc Anvendelse af megestrolacetat til forbedring af hjertefunktion og behandling af hjerteinsufficiens
WO2009145716A1 (fr) * 2008-05-28 2009-12-03 Astrazeneca Ab Nouvelle préparation pharmaceutique utile dans le traitement du reflux gastro-œsophagien pathologique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US4938968A (en) * 1988-07-26 1990-07-03 Norjec Development Associates, Inc. Controlled release indomethacin
NZ230763A (en) * 1988-09-27 1991-10-25 Takeda Chemical Industries Ltd Production of granules having a core by spraying the cores with a dispersion of hydroxypropylcellulose, optionally incorporating an active ingredient

Also Published As

Publication number Publication date
WO1997025028A1 (fr) 1997-07-17
TNSN97001A1 (fr) 2005-03-15
HRP970004A2 (en) 1998-04-30
AU1323897A (en) 1997-08-01
ZA9610888B (en) 1997-07-07
SE9600046D0 (sv) 1996-01-05

Similar Documents

Publication Publication Date Title
DZ2461A1 (fr) Dérivés d'arylkylamines nouveaux et composition pharmaceutiques les contenant.
MA26537A1 (fr) Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant.
DZ1916A1 (fr) Composés nouveaux et compostions pharmaceutiques les contenant.
DZ2086A1 (fr) Benzylaminopipéridines substituées et compositionspharmaceutiques les contenant.
FR2732967B1 (fr) 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
NL194577B (nl) Preparaat voor de lang aanhoudende en gecontroleerde afgifte van medicamenteuze stoffen.
BRPI9810519B1 (pt) derivados de 4''-substituìdo-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos.
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
FR2683531B1 (fr) Nouveaux derives du lupane, leur preparation et les compositions pharmaceutiques qui les contiennent.
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
NO308303B1 (no) Vannløselige rapamycinestere, anvendelse derav samt farmasøytisk blanding som omfatter forbindelsene
BR9804500B1 (pt) derivado de amida, referida composição farmacêutica e agente terapêutico.
MA26714A1 (fr) Composes nouveaux modulateurs de chimiokine ccr5 et compositions pharmaceutiques les contenant
FR2742751B1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
MA26445A1 (fr) Composes azabicycliques condenses avec un noyau pyridone et compositions pharmaceutiques les contenant.
EP0677556A3 (fr) Pigment revêtu et composition colorante.
DE69317389D1 (de) Nachfüllvorrichtung und Entwicklerbehälter, der diese verwendet
FR2811992B1 (fr) Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
EP0830357A4 (fr) Diamines radiosensibilisantes et preparations pharmaceutiques les contenant
MA26416A1 (fr) Perles pharmaceutiques a liberation controlee contenant du furosemide et une composition realisee avec les dites perles.
DE69732649D1 (de) Heteroarylsulfonamidderivate und diese enthaltende pharmazeutische zubereitungen
DE69704060D1 (de) Tetrahydroisochinolinderivate und ihre pharmazeutische anwendung
DE69632344D1 (de) Triterpenderivate und arzneimittel gegen lebererkrankungen
MA26455A1 (fr) Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2731706B1 (fr) Composes heterocycliques aromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations